Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Contexte
Usages traditionnels
Composés actifs
Mécanisme d'action
Preuves cliniques
Aqueous extract and t-DCTN significantly reduced blood glucose and triglyceride levels in diabetic rats [PMID:21140094, 11903418]. Bark infusion reduced plasma triglyceride levels by 40% in hyperlipidemic mice [PMID:15381962].
t-DCTN and essential oils showed significant antiulcerogenic effects in rat models induced by ethanol, hypothermic restraint stress, and pylorus ligature [PMID:9525103, 10344636]. A polysaccharide fraction from leaves also promoted gastroprotection in ethanol-induced models [PMID:27864055].
Fractions of a leaf decoction and the bark's essential oil exhibited anti-inflammatory and antinociceptive properties in rodent models [PMID:28826140, 10678502].
7-hydroxycalamenene-rich essential oils showed activity against MRSA, Mycobacterium tuberculosis, and Candida species [PMID:23325101, 27019560]. Extracts and terpenes showed activity against Leishmania amazonensis and Leishmania chagasi [PMID:24088644, 26547537, 16099722].
Sécurité et effets indésirables
Synthèse des preuves
Sources PubMed
- 1.PMID: 37587801 (2024) — Croton cajucara: Patents and Nanotechnological Advances. · Recent patents on nanotechnology
- 2.PMID: 21140094 (2010) — Hepatics alterations and genotoxic effects of Croton cajucara Benth (SACACA) in diabetic rats. · Arquivos de gastroenterologia
- 3.PMID: 28826140 (2017) — Phytochemical analysis and anti-inflammatory evaluation of compounds from an aqueous extract of Croton cajucara Benth. · Journal of pharmaceutical and biomedical analysis
- 4.PMID: 37886132 (2023) — Red sacaca essential oil-loaded nanostructured lipid carriers optimized by factorial design: cytotoxicity and cellular reactive oxygen species levels. · Frontiers in pharmacology
- 5.PMID: 18372957 (2008)